CANCER IMMUNOTHERAPY MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Table of Contents (Version-2026)

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
• Market Definition and Scope
• Executive Summary
• Market Snapshot, By Therapy Type
• Market Snapshot, By Route of Administration
• Market Snapshot, By Cancer Type
• Market Snapshot, By Distribution Channel
• Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Drivers
• Restraints
• Market Opportunities
• Impact Analysis
• Market Trends
• Recent Developments
• Acquisitions and Partnerships Scenario
• Technology Overview
• Regulatory Scenario
• Pricing Analysis
• PEST Analysis

4. Global Cancer Immunotherapy Market, By Therapy Type, 2021 – 2033, (USD Bn)

• Overview
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2021 – 2033
• Segment Trends
• Immune checkpoint inhibitors
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Vaccines
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Preventive Vaccines
• Therapeutic Vaccines
• Adoptive Cell Therapies
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Tumor-infiltrating lymphocyte (TIL) therapy
• CAR T-cell therapy
• Engineered T-cell receptor (TCR) therapy
• Natural killer (NK) cell therapy
• Immune System Modulators
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Interferons
• Immunomodulators (IMiDs)
• Interleukins
• Monoclonal antibodies
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Naked monoclonal antibodies
• Conjugated monoclonal antibodies
• Bispecific monoclonal antibodies
• Oncolytic Virus Therapy
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)

5. Global Cancer Immunotherapy Market, By Route of Administration, 2021 – 2033, (USD Bn)

• Overview
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2021 – 2033
• Segment Trends
• Subcutaneous 
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Oral
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Intramuscular
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Intravenous (IV)
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Others  
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)

6. Global Cancer Immunotherapy Market, By Cancer Type, 2021 – 2033, (USD Bn)

• Overview
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2021 – 2033
• Segment Trends
• Lymphoma
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Breast Cancer
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Colorectal Cancer
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Bladder Cancer
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Skin Cancer
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Lung Cancer
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Kidney Cancer
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Others
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)

7. Global Cancer Immunotherapy Market, By Distribution Channel, 2021 – 2033, (USD Bn)

• Overview
• Market Share Analysis, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, 2021 – 2033
• Segment Trends
• Hospital Pharmacies
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Retail Pharmacies
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)
• Online Pharmacies
• Overview
• Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Bn)

8. Global Cancer Immunotherapy Market, By Region, 2021 – 2033, (USD Bn)

• Introduction
• Market Share Analysis, By Region, 2026 and 2033 (%)
• Y-o-Y Growth Analysis, For Region, 2021–2033
• Regional Trends
• North America
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
• U.S.
• Canada
• Latin America
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Bn)
• GCC
• Israel
• Rest of Middle East
• Africa
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, By Therapy Type, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2021 - 2033, (USD Bn)
• Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Bn)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Company Profiles
• Gilead Sciences, Inc.
• Company Overview
• Product Portfolio
• Financial Overview
• Key Highlights
• Market Strategies
• Johnson & Johnson  
• Company Overview
• Product Portfolio
• Financial Overview
• Key Highlights
• Market Strategies
• Actym Therapeutics, Inc.
• Company Overview
• Product Portfolio
• Financial Overview
• Key Highlights
• Market Strategies
• Bristol-Myers Squibb Company
• Company Highlights
• Product Portfolio
• Key Highlights
• Financial Performance
• Market Strategies
• Pfizer Inc
• Company Overview
• Product Portfolio
• Financial Overview
• Key Highlights
• Market Strategies
• Novartis AG
• Company Overview
• Product Portfolio
• Financial Overview
• Key Highlights
• Market Strategies
• Merck & Co., Inc.
• Company Overview
• Product Portfolio
• Financial Overview
• Key Highlights
• Market Strategies
• Fate Therapeutics
• Company Overview
• Product Portfolio
• Financial Overview
• Key Highlights
• Market Strategies
• AstraZeneca
• Company Overview
• Product Portfolio
• Financial Overview
• Key Highlights
• Market Strategies
• Amgen Inc.
• Company Overview
• Product Portfolio
• Financial Overview
• Key Highlights
• Market Strategies
• GSK plc.  
• Company Overview
• Product Portfolio
• Financial Overview
• Key Highlights
• Market Strategies
• Acumen Pharmaceuticals, Inc
• Company Overview
• Product Portfolio
• Financial Overview
• Key Highlights
• Market Strategies
• Arcus Biosciences, Inc.
• Company Overview
• Product Portfolio
• Financial Overview
• Key Highlights
• Market Strategies
• BioNTech SE  
• Company Overview
• Product Portfolio
• Financial Overview
• Key Highlights
• Market Strategies
• Cellectis  
• Company Overview
• Product Portfolio
• Financial Overview
• Key Highlights
• Market Strategies
• immunitybio inc
• Company Overview
• Product Portfolio
• Financial Overview
• Key Highlights
• Market Strategies
• Autolus Therapeutics
• Company Overview
• Product Portfolio
• Financial Overview
• Key Highlights
• Market Strategies
• ADC Therapeutics SA.  
• Company Overview
• Product Portfolio
• Financial Overview
• Key Highlights
• Market Strategies
• Gritstone bio  
• Company Overview
• Product Portfolio
• Financial Overview
• Key Highlights
• Market Strategies
• Incyte
• Company Overview
• Product Portfolio
• Financial Overview
• Key Highlights
• Market Strategies

10. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact